Search for:
Search for:
Healthcare Professionals
Publications
Contact
News
Español
Magazine
Radio
*
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Supporter Program
Awareness Campaigns
Host an Event
Events
MS Focus on Fashion
The inaugural MS Focus on Fashion, will take place on Nov. 6, in Dania Beach, Fla.
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News
Brighter Tomorrow Grant
The Brighter Tomorrow Grant allows MS Focus to makes dreams come true for people with MS across...
/Get-Help/MSF-Programs-Grants/Brighter-Tomorrow-Grant
Shop
Privacy
Terms of Use
Site Map
Monocytes may play key role in myelin damage
April 24, 2020
According to findings in a recent study, it is possible that the T and B cells are only indirectly involved in stripping away the myelin sheath in that they prompt a type of monocyte cell to attack myelin. If true, in the future most forms of MS could be treated by specifically deactivating monocytes, protecting the body's immune memory and prevent many side effects of current MS therapies.
Scientists don't yet know exactly which immune cells are involved in stripping away the myelin sheath. Autoreactive T and B cells, which wrongly identify the myelin sheath as a foreign body, travel to the brain and initiate the disease.
Researchers at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, in Berlin, wanted to know what role immune cells – particularly those that are part of innate immunity – play in the development of MS and whether they represent a promising target structure for therapy of MS patients. In an earlier mouse model study, research showed disease symptoms in the mice declined significantly within a few days after their monocytes were selectively destroyed by antibodies. This result surprised the researchers. Apparently, it is not only T and B cells that are involved in causing tissue damage in MS.
The monocytes they studied are a special type of white blood cells that shortly circulate in the blood before migrating into tissue. Once there, they transform themselves into effector cells (phagocytes) and destroy foreign tissue in the central nervous system – or which, during MS, they wrongly identify as such.
In the current study, which was conducted in collaboration with an Israeli team at the Department of Immunology at the Weizmann Institute of Science, in Rehovot, Israel, the research team also focused on monocytes. They identified six different monocyte subtypes, four of which were previously unknown. As in his earlier study, researchers injected the mice with antibodies against a specific monocyte surface protein. As expected, the cells died and the MS symptoms in the mice decreased within a short period of time.
Only a certain type of monocyte, the Cxcl10+ cells, was destroyed by the antibody treatment. These are apparently the cells that are primarily responsible for causing MS tissue damage in the brain. With the help of single-cell sequencing, the team discovered this cell type differs from other monocytes in two essential ways. First, Cxcl10+ cells have a particularly large number of receptors for a signal protein secreted by T cells that induces tissue damaging properties in monocytes. Second, these cells produce large amounts of interleukin-1-beta, a substance that opens the blood-brain barrier, enabling immune cells to more easily pass from the blood to the brain and exacerbate the symptoms. The findings suggest T cells, as disease initiators, travel to the central nervous system in order to lure there the monocytes that are responsible for the primary tissue damage.
The other monocyte subsets that were identified are perhaps even involved in repair processes in which the body tries to rebuild the damaged myelin. In light of the study's findings, the researchers think it is also possible that the T and B cells are not even directly involved in stripping away the myelin sheath, but only indirectly in that they prompt the Cxcl10+ monocytes to attack the protective layer of the axons. If that is the case, in the future most forms of MS could be treated by specifically deactivating the Cxcl10+ monocytes instead of targeting the T or B cells of the immune system. This would protect the body's immune memory and prevent many side effects of current MS therapies. The research team plan to investigate whether the Cxcl10+ monocytes are also present outside the CNS. If they exist in the body's periphery, for example, in the lymph nodes. There they would be easier to target with therapeutics than in the brain.
The study was published in
Nature Immunology
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more